.

Deeper Knowledge, Faster

  • Anticipate your formulary budget
  • Predict branded drug patent expiration
  • Identify first generic entrants

► See Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Novartis
Accenture
Dow
Merck
Healthtrust
McKesson
Boehringer Ingelheim
Cerilliant
Chinese Patent Office
McKinsey

Generated: June 22, 2017

DrugPatentWatch Database Preview

ISOSULFAN BLUE Drug Profile

« Back to Dashboard

Which patents cover Isosulfan Blue, and what generic Isosulfan Blue alternatives are available?

Isosulfan Blue is a drug marketed by Aurobindo Pharma Ltd and Mylan Institutional and is included in two NDAs.

The generic ingredient in ISOSULFAN BLUE is isosulfan blue. There are five drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the isosulfan blue profile page.

Summary for Tradename: ISOSULFAN BLUE

Patents:0
Applicants:2
NDAs:2
Suppliers / Packagers: see list2
Bulk Api Vendors: see list8
Clinical Trials: see list209
Patent Applications: see list3
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:ISOSULFAN BLUE at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Aurobindo Pharma Ltd
ISOSULFAN BLUE
isosulfan blue
INJECTABLE;INJECTION206831-001Feb 2, 2016APRXNoNo► Subscribe► Subscribe
Mylan Institutional
ISOSULFAN BLUE
isosulfan blue
INJECTABLE;INJECTION090874-001Jul 20, 2010APRXNoYes► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Novartis
Citi
Fuji
Queensland Health
Teva
Mallinckrodt
Farmers Insurance
US Department of Justice
Healthtrust
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot